Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
- 17 October 2007
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 155 (1), 82-86
- https://doi.org/10.1016/j.ahj.2007.08.023
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart DiseaseCirculation, 2007
- Alcohol Consumption and Risk of Heart Failure in the Physicians’ Health Study ICirculation, 2007
- Cystatin C, Left Ventricular Hypertrophy, and Diastolic Dysfunction: Data From the Heart and Soul StudyJournal of Cardiac Failure, 2006
- Kidney Function and Systolic Blood Pressure New Insights From Cystatin C: Data from the Heart and Soul StudyAmerican Journal of Hypertension, 2006
- Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient miceAtherosclerosis, 2005
- Lysosomal Cysteine Proteases in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Estimation of glomerular filtration rate in the elderly: a comparison of creatinine‐based formulae with serum cystatin CJournal of Internal Medicine, 2004
- Mild renal insufficiency and risk of congestive heart failure in men and women ≥70 years of ageThe American Journal of Cardiology, 2003
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989